Detalles de la búsqueda
1.
Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
J Hepatol
; 63(6): 1360-7, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26232269
2.
Usefulness of contrast-enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B-mode ultrasound.
Hepatol Res
; 45(3): 337-42, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24773617
3.
Therapeutic effects of the direct renin inhibitor, aliskiren, on non-alcoholic steatohepatitis in fatty liver Shionogi ob/ob male mice.
Hepatol Res
; 44(8): 888-896, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23777387
4.
Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model.
Hepatol Res
; 43(5): 547-56, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23057725
5.
Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
PLoS One
; 15(2): e0219412, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106257
6.
[A case of AFP-producing gastric cancer responding to the combination of systemic chemotherapy, transcatheter arterial embolization and hepatic infusion chemotherapy].
Gan To Kagaku Ryoho
; 36(5): 843-6, 2009 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-19461191
7.
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
Int J Mol Med
; 38(3): 721-8, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27431935
8.
A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
PLoS One
; 11(5): e0154676, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27135827
9.
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model.
World J Hepatol
; 8(22): 933-41, 2016 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27574547
10.
Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice.
Mol Med Rep
; 12(5): 6895-902, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26397061
11.
Rapid and early α-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma.
Mol Clin Oncol
; 3(3): 655-662, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26137283
12.
Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression.
J Gastroenterol
; 48(11): 1283-92, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23338488
13.
Assessment of track microbubble flow signals on contrast-enhanced ultrasound with perflubutane following percutaneous liver biopsy.
Intern Med
; 52(13): 1455-9, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23812191
14.
Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Eur J Radiol
; 81(10): 2730-6, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22137612
15.
Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
Int J Mol Med
; 30(1): 107-13, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22469867
Resultados
1 -
15
de 15
1
Próxima >
>>